12 months from date of receipt / reconstitution, 2 to 8 °C as supplied
应用 | 稀释度 |
---|---|
ELISA | 1.221-5000 ng/ml |
Secukinumab is a human IgG1κ monoclonal antibody used for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. It binds to the protein interleukin (IL)-17A.
Immobilized human IL-17A at 0.5 μg/ml (50 μL/well) can bind to Secukinumab with a linear range of 1.221 ng/ml-5 μg/ml.